Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 140

Showing 26-50 of 140 citing articles:

A complex case of mixed phenotype acute leukaemia, B/T/myeloid
Nourhan Ibrahim, Z Aljumaili, Phuoc T. Christie-Nguyen, et al.
Pathology (2025)
Closed Access
Impact of ASXL1 Gene Alterations on Myelodysplastic Syndrome With Isolated 20q Deletion
Yanan Chang, Linlin Liu, Chenghua Cui, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Big data analytics and machine learning in hematology: Transformative insights, applications and challenges
Emmanuel Ifeanyi Obeagu, Christiana Uchenna Ezeanya, Fabian Chukwudi Ogenyi, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41766-e41766
Open Access
Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives
Laras Pratiwi, Fawzia Hanum Mashudi, Mukti Citra Ningtyas, et al.
Hematology Reports (2025) Vol. 17, Iss. 2, pp. 18-18
Open Access
European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies
John G. Gribben, Leticia Quintanilla‐Martinez, Simon Crompton, et al.
HemaSphere (2025) Vol. 9, Iss. 4
Open Access
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
Blood Reviews (2023) Vol. 60, pp. 101072-101072
Closed Access | Times Cited: 12
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT
Carmelo Gurnari, Marie Robin, Lucy A. Godley, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 12, pp. e994-e1005
Closed Access | Times Cited: 12
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
Laura Calabresi, Chiara Carretta, Simone Romagnoli, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1520-1531
Open Access | Times Cited: 11
SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Ilaria Iacobucci, Andy G.X. Zeng, Qingsong Gao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
TP53 in AML and MDS: The new (old) kid on the block
Jennifer A. Marks, Xin Wang, Elena M. Fenu, et al.
Blood Reviews (2023) Vol. 60, pp. 101055-101055
Closed Access | Times Cited: 10
Metabolic crosstalk between stromal and malignant cells in the bone marrow niche
Hernán A. Tirado, Nithya Balasundaram, Lotfi Laaouimir, et al.
Bone Reports (2023) Vol. 18, pp. 101669-101669
Open Access | Times Cited: 10
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
Enrico Attardi, Arianna Savi, Beatrice Borsellino, et al.
Blood Advances (2023) Vol. 7, Iss. 17, pp. 5122-5131
Open Access | Times Cited: 10
Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases
Aakash Desai, Lincoln W. Pasquina, Candice Nulsen, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100140-100140
Open Access | Times Cited: 3
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
Erika Morsia, Elena Torre, Francesco Martini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1524-1524
Open Access | Times Cited: 3
Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges
Yuhang Xue, Xuejiao Xia, Xin Liu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 3
Cancer cytogenetics in a genomics world: Wedding the old with the new
Jorune Balciuniene, Yi Ning, Hillard M. Lazarus, et al.
Blood Reviews (2024) Vol. 66, pp. 101209-101209
Closed Access | Times Cited: 3
Considering clonal hematopoiesis of indeterminate potential in space radiation risk analysis for hematologic cancers and cardiovascular disease
Charles M. Werneth, Zarana S. Patel, Moriah S. Thompson, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 3
Advances in the Classification of Myeloid and Lymphoid Neoplasms
Daniel A. Arber, Elı́as Campo, Elaine S. Jaffe
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 1-9
Open Access | Times Cited: 15
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumor-only <i>versus</i> paired tumor-normal sequencing
Haley Newman, M. Clark, Derek Wong, et al.
Haematologica (2024)
Open Access | Times Cited: 2
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
Ian M. Bouligny, Graeme Murray, Michael Doyel, et al.
Medical Oncology (2024) Vol. 41, Iss. 3
Closed Access | Times Cited: 2
A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications
Matteo Giovanni Della Porta, Giovanni Martinelli, Alessandro Rambaldi, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104358-104358
Closed Access | Times Cited: 2
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, et al.
Leukemia (2024) Vol. 38, Iss. 7, pp. 1626-1629
Open Access | Times Cited: 2
SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia
Ilaria Iacobucci, Cristina Papayannidis
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access | Times Cited: 2
Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies
Tiffany Nong, Shefali Mehra, Justin Taylor
Cells (2024) Vol. 13, Iss. 16, pp. 1392-1392
Open Access | Times Cited: 2
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis
Brunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti
American Journal of Hematology (2023) Vol. 98, Iss. 4, pp. 550-552
Open Access | Times Cited: 6

Scroll to top